Vartan Mardigyan

Vartan Mardigyan

Auto-generated profile, based on publicly available information

Vartan Mardigyan

Department of Medicine, Jewish General Hospital , Montreal

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2016 in JACC: Clinical Electrophysiology
Verified
Journal Article
Closed access
LBLior Bibas
Lior Bibas
MLMichael Levi
Michael Levi
JTJacynthe Touchette
Jacynthe Touchette
VMVartan Mardigyan
Vartan Mardigyan
MBMartin Bernier
Martin Bernier
JAJonathan Afilalo
Jonathan Afilalo

1 April 2005 in Clinical Therapeutics
Verified
Journal Article
Closed access
VMV Mardigyan
V Mardigyan
JTJ Tchervenkov
J Tchervenkov
Peter MetrakosPeter Metrakos
Peter Metrakos
JBJ Barkun
J Barkun
MDM Deschenes
M Deschenes
MCM Cantarovich
M Cantarovich

29 July 2025 in EP Europace
Verified
Journal Article
Open access
JJJacqueline Joza
Jacqueline Joza
JLJustin Luermans
Justin Luermans
VMVartan Mardigyan
Vartan Mardigyan
HBHaran Burri
Haran Burri
MJMarek Jastrzębski
Marek Jastrzębski
KVKevin Vernooy
Kevin Vernooy
Biventricular pacing remains the cornerstone of cardiac resynchronization therapy (CRT) in patients with heart failure, with well-established benefits. Left bundle branch pacing (LBBP) offers a physiologic alternative by engaging the native conduction system to restore synchrony and has generated significant enthusiasm. However, the growing adoption of LBBP should be tempered by recognition that a one-size-fits-all approach may not address the underlying substrate, particularly in those with intraventricular conduction delay. While a less-than-optimal LBBP implant may be sufficient in bradycardia patients, its adequacy in heart failure patients, who may require more precise consideration of conduction disease, remains uncertain. This review gives a comprehensive framework for integrating LBBP into CRT, including pre-implant, intraprocedural, and post-implant assessment. It also provides practical guidance on when to pursue LBBP alone, when to supplement with a coronary sinus lead, and when to consider conventional biventricular pacing, with an emphasis on a personalized approach to the underlying conduction substrate for maximal therapeutic benefit.